glp-1 news today obesity drug updates What is the pipeline for future medications for obesity? Professor Receives Grant to Study

Financing or payment-plan options may be availablecheck with the clinic

Pharmacokinetics: Approximately 79% of sitagliptin is excreted unchanged in the urine & metabolism is a minor pathway for elimination

Myth: GLP-1 patches do not have side effects

Many practices pair it with aesthetic services such as Botox training and dermal filler training, and our Medspa Business & Marketing Masterclass covers turning those services into a viable practice.

This synergy helps restore natural radiance and a more luminous complexion

Scientific Overview BPC-157 (15 amino acids) A synthetic pentadecapeptide derived from the Body Protection Compound, studied in preclinical models for its interaction with growth factors, angiogenesis, and inflammatory signaling pathways